PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Similar documents
Fort Detrick, Maryland

CONTRACTING ORGANIZATION: University of California Lawrence Berkeley National Laboratory Berkeley, CA 94720

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AWARD NUMBER: W81XWH TITLE: Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury with Deep Brain Stimulation

CONTRACTING ORGANIZATION: Western Institute For Biomedical Research Salt Lake City, UT

TITLE: Dietary Genistein and Prostate Cancer Chemoprevention

TITLE: New Advanced Technology to Improve Prediction and Prevention of Type 1 Diabetes

Award Number: W81XWH

CONTRACTING ORGANIZATION: North Eastern Ohio Universities Rootstown OH 44202

Award Number: W81XWH TITLE: Global Positioning Systems (GPS) Technology to Study Vector-Pathogen-Host Interactions

TITLE: Neural Protein Synuclein (SNCG) in Breast Cancer Progression

Approved for public release; distribution unlimited

Promote Adjustment during Reintegration following Deployment

TITLE: Post-Traumatic Headache and Psychological Health: Mindfulness Training for Mild Traumatic Brain Injury

TITLE: 64Cu-DOTA-trastuzumab PET imaging in women with HER2 overexpressing breast cancer

TITLE: Targeting the Immune System s Natural Response to Cell Death to Improve Therapeutic Response in Breast Cancers

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: Johns Hopkins Bloomberg School of Public Health

CONTRACTING ORGANIZATION: Regents of the University of Michigan Ann Arbor, MI 48109

CONTRACTING ORGANIZATION: Spaulding Rehabilitation Hospital, Boston, MA 02129

CONTRACTING ORGANIZATION: Cold Spring Harbor Laboratory Cold Spring Harbor, NY 11724

Award Number: W81XWH

TITLE: Evaluation of DNA Methylation as a Target for Intraductal Therapy for Ductal Carcinoma in Situ of the Breast

TITLE: Maximizing Energy After Traumatic Brain Injury: A Novel Intervention

CONTRACTING ORGANIZATION: Sloan-Kettering Institute for Cancer Research New York, NY 10021

Detection of Prostate Cancer Progression by Serum DNA Integrity

CONTRACTING ORGANIZATION: Veterans Medical Research Foundation San Diego, CA

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Oxidative Stress, DNA Repair and Prostate Cancer Risk. PRINCIPAL INVESTIGATOR: Hua Zhao, Ph.D.

TITLE: Enhancing the Anti-Tumor Activity of ErbB Blockers with Histone Deaccetylase (HDAC) Inhibition in Prostate Cancer Cell Lines

AD (Leave blank) TITLE: Proteomic analyses of nipple fluid for early detection of breast cancer

TITLE: Responsiveness of a Neuromuscular Recovery Scale for Spinal Cord Injury: Inpatient and Outpatient Rehabilitation

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

CONTRACTING ORGANIZATION: UNIVERSITY OF ILLINOIS Chicago, IL 60612

Approved for public release; distribution unlimited

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AD (Leave blank) TITLE: Trial of Naltrexone and Dextromethorphan for Gulf War Veterans Illnesses

Sphingosine-1-Phosphate Receptor Subtype 3: A Novel Therapeutic Target of K-Ras Mutant Driven Non-Small Cell Lung Carcinoma

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AWARD NUMBER: W81XWH TITLE: Gulf War Illness as a Brain Autoimmune Disorder. PRINCIPAL INVESTIGATOR: Apostolos Georgopoulos, MD, PhD

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AD (Leave blank) Award Number: W81XWH TITLE: Targeting Autophagy for the Treatment of TSC and LAM. PRINCIPAL INVESTIGATOR: Elizabeth Henske

Award Number: W81XWH TITLE: "Longitudinal Study of a Novel Performance-based Measure of Daily Function."

TITLE: Identification of New Serum Biomarkers for Early Breast Cancer Diagnosis and Prognosis Using Lipid Microarrays.

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine, New York, NY 10029

TITLE: Genes Associated with Food Allergy and Eosinophilic Esophagitis

TITLE: Targeted Eradication of Prostate Cancer Mediated by Engineered Mesenchymal Stem Cells

Page 1 AWARD NUMBER: W81XWH TITLE: A Novel Pleiotropic Anti-Inflammatory Drug to Reduce ARDS Incidence. PRINCIPAL INVESTIGATOR: Gary Nieman

TITLE: TREATMENT OF ENDOCRINE-RESISTANT BREAST CANCER WITH A SMALL MOLECULE C-MYC INHIBITOR

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, MD

RECIPIENT: Lankenau Institute for Medical Research, Wynnewood, PA 19096

TITLE: Long Term Outcomes of BRCA1/BRCA2 Mutation Testing. CONTRACTING ORGANIZATION: Georgetown University Washington, DC

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

AD (Leave blank) TITLE: Brief cognitive behavioral therapy for military populations

CONTRACTING ORGANIZATION: Oregon Health & Science University Portland OR 97239

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: MicroRNA in Prostate Cancer Racial Disparities and Aggressiveness

TITLE: Adipose Estrogen and Increased Breast Cancer Risk in Obesity: Regulation by Leptin and Insulin

TITLE: Harnessing GPR17 Biology for Treating Demyelinating Disease

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland X Approved for public release; distribution unlimited

TITLE: Prevention and Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

TITLE: Prazosin for Treatment of Patients With PTSD and Comorbid Alcohol Dependence

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Short-Term Exercise and Prostate Cancer Prevention in African American Men. CONTRACTING ORGANIZATION: Howard University Washington DC 20059

TITLE: A Tissue Engineering Approach to Study the Progression of Breast Tumor Metastasis in Bone

CONTRACTING ORGANIZATION: University of Minnesota St Paul, MN 55108

TITLE: Determination of Optimum Vitamin D Nutrition in Young Women. Omaha, NE 68178

AWARD NUMBER: W81XWH TITLE: Androgen Deprivation Therapy and Cognitive Impairment. PRINCIPAL INVESTIGATOR: Robert N. Pechnick, Ph.D.

TITLE: Properties of Leukemia Stem Cells in a Novel Model of CML Progression to Lymphoid Blast Crisis

TITLE: Mission Connect Mild TBI Translational Research Consortium. U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: Computerized Tailored Interventions for Behavioral Sequelae of Post-Traumatic Stress Disorder in Veterans

TITLE: Directing Spinal Cord Plasticity: The Impact of Stretch Therapy on Functional Recovery after Spinal Cord Injury.

TITLE: "Impact of Obesity on Tamoxifen Chemoprevention in a Model of Ductal Carcinoma in Situ"

TITLE: Inhibitors of Histone Deacetylases for Radiosensitization of Prostate Cancer

TITLE: Genetic and epigenetic biomarkers for recurrent prostate cancer after radiotherapy

TITLE: Gulf War Illness Evaluation of an innovative detoxification program

Award Number: W81XWH TITLE: Characterizing an EMT Signature in Breast Cancer. PRINCIPAL INVESTIGATOR: Melanie C.

CONTRACTING ORGANIZATION: Fred Hutchinson Cancer Research Center Seattle, WA 98109

TITLE: Improving Work Outcomes for Veterans with Traumatic Brain Injury. San Diego, CA 92161

Award Number: W81XWH TITLE: A Novel Membrane-Permeable, Breast-Targeting, Pro-Apoptotic Peptide for Treatment of Breast Cancer

TITLE: A PSCA Promoter Based Avian Retroviral Transgene Model of Normal and Malignant Prostate

CONTRACTING ORGANIZATION: Vanderbilt University Medical Center Nashville, TN

TITLE: Investigation of the Akt/PKB Kinase in the Development of Hormone-Independent Prostate Cancer

TITLE: Effects of Tobacco Smoke (TS) on growth of clear cell renal cell carcinoma (ccrcc)

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

TITLE: The Role Of Alternative Splicing In Breast Cancer Progression

TITLE: Establishing the Mineral Apposition Rate of Heterotopic Ossification for Prevention of Recurrence.

TITLE: Interchromosomal Associations that Alter NF1 Gene Expression Can Modify Clinical Manifestations of Neurofibromatosis 1. Palo Alto, CA 94304

Award Number: W81XWH TITLE: Dietary Fish Oil in Reducing Bone Metastasis of Breast Cancer

CONTRACTING ORGANIZATION: University of Texas M.D. Anderson Cancer Center Houston, TX 77030

TITLE: Homeostatic and Circadian Abnormalities in Sleep and Arousal in Gulf War Syndrome

CONTRACTING ORGANIZATION: Mount Sinai School of Medicine New York, New York

TITLE: Role of ADAM15 in Tumor/Endothelial Interactions Prostate Cancer Regression

TITLE: The Role of HOX Proteins in Androgen-Independent Prostate Cancer

TITLE: Prostate Expression Databases: Gene Expression Resources for Comparative Studies of Prostate Carcinogenesis

Award Number: W81XWH TITLE: Regenerative Stem Cell Therapy for Breast Cancer Bone Metastasis

Transcription:

Award Number: W81XWH-12-1-0445 TITLE: An investigation into the nature of non-voiding contractions resulting from detrusor hyperreflexia in neurogenic bladders following spinal cord injury PRINCIPAL INVESTIGATOR: Matthew O. Fraser, Ph.D. CONTRACTING ORGANIZATION: Institute for Medical Research Durham, NC 27705 REPORT DATE: October 2013 TYPE OF REPORT: Annual PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEMENT: Approved for Public Release; Distribution Unlimited The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

REPORT DOCUMENTATION PAGE Form Approved OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 1. REPORT DATE October 2013 2. REPORT TYPE Annual 3. DATES COVERED 30 September 2012 29 September 2013 4. TITLE AND SUBTITLE 5a. CONTRACT NUMBER An investigation into the nature of non-voiding contractions resulting from detrusor hyperreflexia in neurogenic bladders following spinal cord injury 6. AUTHOR(S) Matthew O. Fraser 5b. GRANT NUMBER W81XWH-12-1-0445 5c. PROGRAM ELEMENT NUMBER 5d. PROJECT NUMBER 5e. TASK NUMBER 5f. WORK UNIT NUMBER E-Mail: matthew.fraser@duke.edu 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER Institute for Medical Research VA Medical Center (151-IMR) 508 Fulton Street Durham, NC 27705 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR S ACRONYM(S) U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 11. SPONSOR/MONITOR S REPORT NUMBER(S) 12. DISTRIBUTION / AVAILABILITY STATEMENT Approved for Public Release; Distribution Unlimited 13. SUPPLEMENTARY NOTES 14. ABSTRACT The purpose of this project is to determine the cause behind non-voiding contractions (NVC) of the bladder seen with filling following suprasacral spinal cord injury (SCI). The most significant findings over the course of the past year have been that NVC in chronic SCI are accompanied by intra-abdominal pressure increases resulting from abdominal wall contraction. The temporal relationship appears to be that of either the abdominal pressure rise beginning just prior to, or simultaneously with, the bladder pressure rise, These results, therefore, strongly suggesting that these abdominal wall-mediated abdominal pressure rises either cause NVC, or arise from the same mass reflex event as the NVC. 15. SUBJECT TERMS Spinal cord injury, neurogenic bladder, detrusor overactivity, detrusor hyperreflexia, mass reflexes, non-voiding contractions 16. SECURITY CLASSIFICATION OF: 17. LIMITATION OF ABSTRACT 18. NUMBER OF PAGES 19a. NAME OF RESPONSIBLE PERSON USAMRMC a. REPORT U b. ABSTRACT U c. THIS PAGE U UU 10 19b. TELEPHONE NUMBER (include area code)

Table of Contents Page Introduction..... 1 Body.. 1 Key Research Accomplishments... 6 Reportable Outcomes 6 Conclusion 6 References. 7 Appendices 7

INTRODUCTION: Suprasacral spinal cord injury (SCI) is often occasioned by numerous, rhythmic high pressure non-voiding contractions (NVC) during normal bladder filling. These NVC are responsible for incontinence episodes, bladder and bladder neck damage, as well as the life threatening consequences of hydronephrosis and autonomic dysreflexia. Our objectives and goals are to determine the relative contributions, if any, of the nervous system (parasympathetic, sympathetic and somatic) and intrinsic myogenic activity on the generation of high pressure NVC in chronic SCI rats with detrusor hyperreflexia and detrusor-sphincter dyssynergia. Once achieved, these insights may be translatable to novel therapeutic approaches toward alleviating detrusor hyperreflexia and detrusor-sphincter dyssynergia in humans with suprasacral spinal cord injury. Our overarching hypothesis is that NVCs in chronic SCI may be augmented by bladderto-bladder parasympathetic reflexes, but are not themselves caused by bladder-to-bladder reflexes. Rather, two other sources are proposed: the first is myogenic filling contractions, which either invade the dome of the bladder causing a large amplitude myogenic contraction or cause a secondary reflex response to distension. This latter possibility is subtly yet importantly different than a response to gradual steady filling, as it implies an episodic distension of the dome which results in the spinal reflex. In either case, diminishing these myogenic contractions should reduce or eliminate the generation of large amplitude NVCs. The second possibility is one of indirect stimulation of the bladder by bladder-to-somatic reflexes, such that bladder filling, be it steady or episodic, evokes a limited mass-reflex of the abdominal musculature. This contraction of abdominal muscle then stimulates the bladder contraction by pressure generation via compression. BODY: The approved tasks of the statement of work are as follows: Task 1. Development, submission and approval of an IACUC protocol covering the intended research (2 months) Task 1 was accomplished and we proceeded to Task 2. Task 2. SA1: Determination of the autonomic neural and myogenic contribution to NVCs in conscious SCI rats. This task will take 18 rats/group in order to achieve 12 rats with detrusor hyperreflexia, detrusor-sphincter DSD and recovered voiding in order to achieve the aim s goals (75% of chronic SCI animals fall into this category, assume a loss of two animals/group due to morbidity/mortality associated with chronic SCI) 2a. Ordering of animals, initial surgical preparation of SCI rats (1.25 months) 2b. Weekly experiments with random assignments of animals to either treatments consistent with SA1a, SA1b, Sa1c or Control across a 14.5 month period (15. 5 months, includes 4 weeks of vacation/holiday time in addition to the 16.5 month experiment period) 2c. Final data analysis (data analysis will be ongoing throughout, this will represent the finalization of data period, 0.25 months) Total Time for Task 2 17 months Total Time for Tasks 1 and 2 19 months 1

Task 2 was partially accomplished. We accomplished Sub-Tasks 2a and 2b. As of 9/29/13, we are in the process of data analysis, but have completed the measurements of the Control Data (repeated vehicle administration) and have analyzed bladder pressure parameters for this group. Other parameters from this group and all data from the other groups at the time need to be measured and/or analyzed. Task 2b - During the course of the first year, we accomplished all of the Specific Aim 1 experiments. This includes the following Specific Aims: The data from the Control group only have been analyzed and demonstrate that repeated vehicle administration had no effect on True Bladder Capacity (TBC; estimated by single fill cystometrogram from empty bladder starting point), Functional Bladder Capacity (FBC; a.k.a. intermicturition interval during continuous cystometry, is affected by residual volumes due to decreased voiding efficiencies and is therefore not an estimate of TBC, but is what one can expect during normal function), or Maximum NVC Amplitude. However, there was a statistically significant increase (albeit not dramatic in physiological significance) in Voiding Efficiency (%VE; P=0.0129 by Friedman Test, p<0.05 for ~10% increase at 4th Vehicle dose. These data can be seen in Figure 1, and these results provide the necessary backdrop for appropriate 2-Way ANOVA analysis for the remaining groups. It is with some relief that we find that there are no physiologically significant effects of repeated vehicle administration, although our study was designed to account for this by inclusion of this very group. 2

True Bladder Capacity 150 100 50 FBC (% Control) 0 Control Vehicle Drug 1 Treatment Drug 2 Drug 3 Control Vehicle Drug 1 Drug 2 Drug 3 NS by Friedman Test Max NVC Amplitude 150 %VE (% Control) Max NVC Amplitude (% Control) 100 50 Control Vehicle Drug 1 Drug 2 Drug 3 0 Control Vehicle Drug 1 Treatment Drug 2 Drug 3 NS by Friedman Test Figure 1 Graphical representations of the repeated vehicle control data from Specific Aim 1. Upper left is True Bladder Capacity, upper right is Functional Bladder Capacity, lower left is Voiding Efficiency, lower right is Maximum NVC Amplitude. Data from each animal have been normalized to the first vehicle response. Drug 1 3 in this case refers to repeated vehicle injections. Note no dramatic effect of repeated vehicle on these parameters of neurogenic bladder function. 3

We also made some general observations, and perhaps the most key of the study thus far. These include that following Hexamethonium administration, all true voiding events (spinal micturition reflex, complete with phasic external urethral sphincter firing) are eliminated, however, voiding occurred by a combination of augmented overflow incontinence (NVC-driven and a vesicosomatic reflex of the hindquarters (Figure 2) Figure 2 Bladder pressure tracing (top panel) and intra-abdominal pressure tracing (bottom panel) following hexamethonium administration. Note that the two traces are quasisuperimposable, suggesting that either the bladder pressure drives the abdominal pressure, or that abdominal pressure is largely responsible for bladder activity under these conditions. Also note that the voiding contraction at the end (black arrow) is not a spinal micturition reflex, but rather an augmented overflow incontinence with a locomotor component (High amplitude pressure swings in bottom trace at time indicated by the black arrow). Additionally, in all animals there was a highly suspicious relationship between intraabdominal pressure and NVCs in the bladder (Figure 3), such that they are either superimposable OR it is clear that the abdominal pressure rise precedes the bladder pressure rise, the latter suggesting that abdominal pressure rise is itself a driving force for the bladder NVC. 4

Figure 3 Superimposed intra-abdominal pressure (purple trace) and bladder pressure (red trace) during an NVC. While the trace suggests that intra-abdominal drives the bladder, one could also argue that both occur at the same time as part of a mass reflex, and that the intraabdominal pressure leads that of the bladder because of the kinetics of striated vs. smooth muscle. Specific Aim 2 will definitively answer this question. We encountered some issues with reliable blood pressure recordings toward the end, but this was due to catheter tip placement and we have remedied this issue. We also had personnel issues, with one technician leaving abruptly and hiring and training a new one. The writing of this report has been delayed, in part, by our lab moving to a new building and maternity leave of the new technician putting many things behind as the PI had to perform many of the duties. All things are now in place and we look forward to a smoother future. Task 3. SA2: Determination of extra-vesicular contributions to NVCs in decerebrate chronic SCI rats. A total of 20 rats will be required to achieve this aim s goal. 18 for the same reasons as given for each group size in Task 2, and an additional 2 rats for mortality/morbidity due to decerebration. 3a. Ordering of animals, initial surgical preparation of SCI rats (1.25 months, but happened during Task 2, so not counted within Task 3) 3b. Weekly experiments across a 4.5 month period. 3c. Data analysis and report writing ongoing and finalized within 0.5 months. 5

Total Time for Task 3 5 months Total Time for Entire Project 24 months As of 9/29/13, we have not begun Task 3. KEY RESEARCH ACCOMPLISHMENTS: Testing of parasympatholytic agents on lower urinary tract function in chronic suprasacral spinal cord injured rats during conscious, restrained cystometry Testing of sympatholytic agents on lower urinary tract function in chronic suprasacral spinal cord injured rats during conscious, restrained cystometry Testing of smooth muscle relaxant agents on lower urinary tract function in chronic suprasacral spinal cord injured rats during conscious, restrained cystometry Testing of repeated vehicle administration on lower urinary tract function in chronic suprasacral spinal cord injured rats during conscious, restrained cystometry Observations of pressure-driven vesico-somatic reflexes resulting in both abdominal contraction and locomotor activity REPORTABLE OUTCOMES: Provide a list of reportable outcomes that have resulted from this research to include: No reportable outcomes as of the end date of this report, but preparation of abstracts for meetings will begin shortly, as soon as the data analyses allow. CONCLUSION: Summarize the results to include the importance and/or implications of the completed research and when necessary, recommend changes on future work to better address the problem. A "so what section" which evaluates the knowledge as a scientific or medical product shall also be included in the conclusion of the report. We have thus far demonstrated that repeated vehicle administration in our hands with our preparation does not result in physiologically significant changes in voiding parameters (with only voiding efficiency being statistically significantly increased by 10% at the fourth vehicle when compared to the second, importantly not the first). This portends well for the comparisons of our results to drug treatments, with analyses underway. We have also observed that intra-abdominal pressure and intravesical pressure have an intimate relationship, suggesting one drives the other, and that may be different depending on the event (baseline vs. NVC). Together with Specific Aim 2, we are poised to determine the relationship between the bladder-to-bladder reflex and either a bladder-to-abdominal musculature-bladder reflex or a bladder-to-mass reflex which drives them both simultaneously. We may also state that none of the drug treatments except for hexamethonium can eliminate the spinal micturition reflex, but this conclusion must be reviewed more carefully to ensure that voiding is not actually occurring by a bladder-to-hindlimb locomotor reflex, driven by high pressures. 6

These results are important, as they will elucidate the relationship(s) between the urinary bladder and the somatic motor system following suprasacral SCI. That abdominal pressure may be responsible for the high pressure NVC seen in this condition dramatically alters our approach in treating this dangerous phenomenon. Best approaches may include elimination of the triggers, likely to be myogenic base-to-dome filling contractions and/or central striated muscle relaxants. REFERENCES: None APPENDICES: None 7